Oct 08, 2018: In today’s increasingly complex clinical development environment, life sciences companies are faced with pressures from regulators, payers, and patients to manage clinical trials and ensure that they are safe, cost-effective, and affordable. To ensure the best possible outcomes for their product, life sciences companies need a reliable, experienced partner who understands how to make insight-driven decisions at every stage of the clinical development lifecycle. With its rich legacy of experience and deep domain expertise, Chennai headquartered TAKE Solutions provides domain-intensive and innovation-led solutions and services for the Life Sciences companies. The company leverages technology and best practices to deliver services that enable businesses across the globe to become more efficient and effective.
End to End Clinical Trial Data Management, Analytics and Submission Services
Clinical trials have become increasingly complex to manage due to the need for deep domain expertise with quality, compliance, and data integrity being the top priorities for sponsors and regulators. Backed by years of clinical research expertise, Navitas Life Sciences - a wholly owned subsidiary and a dedicated life sciences enterprise of TAKE Solutions, works as a strategic partner for large and midsized life science organizations to address critical challenges and achieve successful outcomes in clinical development.
With its OneClinical technology platform, the company drives successful outcomes for global trials by ensuring better trial oversight, delivering high-quality aggregated and integrated data in near real-time, enabling faster decision making and minimizing risks to trial success. Designed for and delivered via cloud and in compliance with regulatory and data privacy requirements, OneClinical serves as the only technology platform for performing end to end clinical trial data management, data visualization, analytics, monitoring and submission services. OneClinical reduces source data verification through industry standards driven central, remote and risk-based monitoring, and enables Data Review, Query Reconciliation and Management through a configurable workflow-based solution.
Beyond trial oversight and centralized monitoring, OneClinical also provides Site Payments, Study Budget Scenario Planning, Interactive Contracts, and Payments dashboards as well as data discrepancy management with the ability to initiate and track actions based on workflows. As a globally recognized and differentiated player, TAKE’s boutique services and portfolio of offerings span the entire spectrum of drug development life cycle and post-approval support.
Industry Specific Technology and Life Sciences Experts
With a team of leading Life Sciences experts, best-in-class systems and processes, and bespoke, industry-specific technology and analytics, TAKE Solutions delivers better outcomes for clients, including 9 of the top 10 global pharmaceutical companies through its 17 offices across 7 countries globally.
“Life Sciences research and development (R&D) services business is a large market of about USD 35-40 billion and for the first nine months of the year we have grown our life science business at 30 percent in dollar terms and 25 percent in rupee terms. As the clinical space is currently witnessing a high degree of consolidation among key players, TAKE Solutions is looking to inorganically add to its portfolio in the clinical and regulatory spaces and is actively engaged in conversations with the right partners in North America.” says Ram Yeleswarapu, President and CEO, TAKE Solutions.
President of Navitas Life Sciences and President and CEO of parent company TAKE Solutions,